Authors/Disclosures
|
Lucas Restrepo, MD, PhD
(UCLA Medical Center)
|
Dr. Restrepo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Restrepo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly USA. Dr. Restrepo has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Kelvi/Hypothermia Devices, Inc.. Dr. Restrepo has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Journals, The Neurohospitalist. Dr. Restrepo has stock in Hypothermia Devices, Inc. (dba Kelvi). Dr. Restrepo has stock in Eli Lilly. Dr. Restrepo has received intellectual property interests from a discovery or technology relating to health care. |
|
Matthew D. Holtkamp, DO
|
Dr. Holtkamp has nothing to disclose. |
|
Supreet K. Sahai, MD
|
Dr. Sahai has received personal compensation in the range of $0-$499 for serving as a Consultant for GLG. Dr. Sahai has received personal compensation in the range of $0-$499 for serving as a Consultant for Guidepoint. |
|
|
No disclosure on file |
|
Adam P. Juersivich, MD
|
No disclosure on file |
|
Alain Vighetto
(Hopital Neuro Pierre Wertheimer)
|
No disclosure on file |
|
Jonathan K. Smith, MD, FAAN
(UC Depart of Neurology & Rehabilitation Medicine)
|
Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for OBT Law. Dr. Smith has a non-compensated relationship as a Committee Member, Clinical Neurophysiology CMOC Pilot, with ABPN that is relevant to AAN interests or activities. |
|
|
No disclosure on file |